Description of Pneumococcal Pneumonia

CompletedOBSERVATIONAL
Enrollment

412

Participants

Timeline

Start Date

December 21, 2017

Primary Completion Date

December 6, 2019

Study Completion Date

January 3, 2020

Conditions
Community-acquired Pneumonia
Interventions
OTHER

Signs of CAP and a positive chest X-Ray

"* collection of clinical examination data~* biological and bacteriological examinations (blood, urine, sputum, nasopharyngeal)~* self-reported questionnaires on duration of symptoms and restriction of activity~* telephone contact on day 28 and day 90 if hospitalized before day 28"

OTHER

Patients directly hospitalized

"* collection of clinical examination data~* telephone contact on day 28 and retrieval of hospitalization report~* telephone contact on day 90"

DIAGNOSTIC_TEST

Control patients

\- bacteriological examinations (urine)

OTHER

Patients with partial participation

\- collection of clinical examination data

OTHER

Signs of CAP and a negative chest X-Ray

"* collection of clinical examination data~* telephone contact on day 28"

Trial Locations (1)

75006

URC-CIC Paris Descartes-Cochin-Necker, Paris

All Listed Sponsors
lead

CNGE Conseil

OTHER

NCT03322670 - Description of Pneumococcal Pneumonia | Biotech Hunter | Biotech Hunter